Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 5 Sep 2020 - 11 Sep 2020
STUDY TYPE:Animal Studies, Pharmacology/Drug Development
DATE PUBLISHED: 2020
JOURNAL:Drug Des Devel Ther
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/32884239?dopt=Abstract
Volume:14
Legalization of cannabis encourages the development of specific cultivars to treat disease such as neuropathic pain. Because of the large number of cultivars, it is necessary to prioritize extracts before proceeding to clinical trials.